register

News - MedTech & Diagnostics

$1 billion Westmead redevelopment set to open in early 2021

Health Industry Hub | November 11, 2020 |

MedTech News: Western Sydney Local Health District and Sydney Children’s Hospitals Network have signed an agreement to ensure they work as partners across the Precinct to deliver the best patient care.

The flagship of the more than $1 billion Westmead Redevelopment, the Central Acute Services Building (CASB) sits between the adult and children’s existing hospitals on Hawkesbury Road at Westmead. It features two new emergency departments – one for adults and one for children.

The 14-level building is set to open in early 2021 after completion was fast-tracked by Health Infrastructure in May this year. It includes operating theatres, medical imaging, pharmacy, more than 300 patient rooms, and education, training and research facilities on every floor.

Western Sydney Local Health District (WSLHD) chief executive Graeme Loy and Sydney Children’s Hospital Network (SCHN) chief executive Cathryn Cox met on Tuesday to sign the historic agreement and commit to principles including collaboration, openness, trust, respect, empowerment and integrity.

While each organisation will maintain total responsibility for its operations, representatives will form a steering committee to work on the joint objective of making Westmead Health Precinct a leader in health services, research, education, advocacy and innovation.

Mr Loy said he was thrilled to usher in a new era of patient care in Westmead Health Precinct.

“This is the first time we’ve brought together Western Sydney Local Health District with the Sydney Children’s Hospitals Network, as well as University of Sydney, to create a space of high-quality care, learning and innovation,” he said.

Ms Cox said the formalising of its partnership with WSLHD was a commitment to transforming healthcare for the community across western Sydney and New South Wales.

“The redevelopment project has enabled us, and our partners, to rethink the way we deliver healthcare. The collaborative approach to the project will continue when the new building opens and we see the additional benefits of working alongside our colleagues in research, education and clinical care across the age spectrum.

The Westmead Health Precinct is one of the largest health, education, research, innovation and training precincts in Australia, featuring four major hospitals, four world-leading medical research institutes, two university campuses and the largest research intensive pathology service in NSW.


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.